PortfoliosLab logoPortfoliosLab logo
KEMX vs. NVOH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

KEMX vs. NVOH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KEMX achieves a 40.15% return, which is significantly higher than NVOH's -0.97% return.


KEMX

1D
1.31%
1M
2.22%
YTD
40.15%
6M
41.62%
1Y
68.58%
3Y*
28.53%
5Y*
13.57%
10Y*

NVOH

1D
0.00%
1M
9.60%
YTD
-0.97%
6M
-3.24%
1Y
-22.77%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

KEMX vs. NVOH - Yearly Performance Comparison


Correlation

The correlation between KEMX and NVOH is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Jan 7, 2025

0.19

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KEMX vs. NVOH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KEMX
KEMX Risk / Return Rank: 8888
Overall Rank
KEMX Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
KEMX Sortino Ratio Rank: 8484
Sortino Ratio Rank
KEMX Omega Ratio Rank: 8989
Omega Ratio Rank
KEMX Calmar Ratio Rank: 8888
Calmar Ratio Rank
KEMX Martin Ratio Rank: 8989
Martin Ratio Rank

NVOH
NVOH Risk / Return Rank: 66
Overall Rank
NVOH Sharpe Ratio Rank: 66
Sharpe Ratio Rank
NVOH Sortino Ratio Rank: 66
Sortino Ratio Rank
NVOH Omega Ratio Rank: 66
Omega Ratio Rank
NVOH Calmar Ratio Rank: 55
Calmar Ratio Rank
NVOH Martin Ratio Rank: 66
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KEMX vs. NVOH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KEMXNVOHDifference
Sharpe ratioReturn per unit of total volatility

+3.20

Sortino ratioReturn per unit of downside risk

+3.63

Omega ratioGain probability vs. loss probability

1.49

0.95

+0.54

Calmar ratioReturn relative to maximum drawdown

4.49

-0.49

+4.98

Martin ratioReturn relative to average drawdown

16.95

-0.78

+17.73

KEMX vs. NVOH - Sharpe Ratio Comparison

The current KEMX Sharpe Ratio is 2.74, which is higher than the NVOH Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of KEMX and NVOH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

KEMX vs. NVOH - Drawdown Comparison

The maximum KEMX drawdown since its inception was -38.80%, smaller than the maximum NVOH drawdown of -61.60%. Use the drawdown chart below to compare losses from any high point for KEMX and NVOH.


Loading charts...

Drawdown Indicators


KEMXNVOHDifference

Max Drawdown

Largest peak-to-trough decline

-38.80%

-61.60%

+22.80%

Max Drawdown (1Y)

Largest decline over 1 year

-15.36%

-46.22%

+30.86%

Max Drawdown (3Y)

Largest decline over 3 years

-19.62%

Max Drawdown (5Y)

Largest decline over 5 years

-30.85%

Current Drawdown

Current decline from peak

-4.61%

-47.89%

+43.28%

Average Drawdown

Average peak-to-trough decline

-8.82%

-38.76%

+29.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.06%

29.21%

-25.15%

Volatility

KEMX vs. NVOH - Volatility Comparison

KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) has a higher volatility of 12.89% compared to Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) at 11.15%. This indicates that KEMX's price experiences larger fluctuations and is considered to be riskier than NVOH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KEMXNVOHDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.89%

11.15%

+1.74%

Volatility (6M)

Calculated over the trailing 6-month period

23.20%

36.97%

-13.77%

Volatility (1Y)

Calculated over the trailing 1-year period

25.17%

49.38%

-24.21%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.97%

48.74%

-29.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.33%

48.74%

-27.41%

KEMX vs. NVOH - Expense Ratio Comparison

KEMX has a 0.25% expense ratio, which is higher than NVOH's 0.19% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.


Dividends

KEMX vs. NVOH - Dividend Comparison

KEMX's dividend yield for the trailing twelve months is around 2.34%, less than NVOH's 6.53% yield.


PositionTTM2025202420232022202120202019
KEMX
KraneShares MSCI Emerging Markets ex China Index ETF
2.34%3.28%3.39%2.00%4.10%4.79%1.69%2.77%
NVOH
Novo Nordisk A/S (B Shares) ADRhedged ETF
6.53%2.38%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


KEMX and NVOH have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KEMX has higher volatility (12.89%) compared to NVOH (11.15%). In terms of maximum drawdown, KEMX dropped -38.80% vs NVOH's -61.60%.

On 1-year performance, KEMX leads with 68.58% vs -22.77% for NVOH. On fees, NVOH is cheaper at 0.19% per year. On volatility, NVOH has been the lower-risk option at 11.15%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, KEMX has performed better with a 68.58% return vs -22.77%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

NVOH is cheaper with a 0.19% expense ratio, compared with 0.25% for KEMX.

NVOH has the higher dividend yield at 6.53%, compared with 2.34% for KEMX.

They also come from different issuers: CICC and Precidian. Their fees differ too: 0.25% for KEMX and 0.19% for NVOH.

KEMX currently has the higher Sharpe Ratio (2.74 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KEMX and NVOH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer